Digital Pathology Market - North America to Dominate the Market by 2022


No comments posted yet


Slide 1

Digital Pathology Market - North America to Dominate the Market by 2022 Market Research Engine has published a new report titled as “Digital Pathology Market By Product Segment Analysis (Whole Slide Imaging, Information Management System Storage & Communication, Image Analysis – Informatics); By End-user Analysis (Hospitals and diagnostic centers, Educational Institutes, Pharmaceutical & biotechnology companies) and By Regional Analysis – Global Forecast by 2016 – 2022”. The Global Digital Pathology Market is expected to exceed more than US$ 1052 million by 2022 and will grow at a CAGR of more than 12% in the given forecast period. Inside the modern day method, the glass slides containing specimen samples are transformed into clean viewing, analysis, storage, and control of the amassed information. This is enabled in element with the aid of virtual microscopy, a generation that permits a success photograph posting and transmission over a related network. The records wealthy photograph bureaucracy the bottom for upkeep of digital health statistics of the affected person population and compile the allotted facts to build a principal database. The advancements in virtual pathology are expected to take the conventional pathology to a greater advanced stage. Digitalization of pathology has led to the automation of the exams at some point of prognosis, hence saving fee and efforts. Browse Full Report: pathology-market The major driving factors of Global Digital Pathology Market are as follows: Efficient rate of digital pathology products High effectiveness of digital pathology systems Simplicity of transportation of slides virtually The restraining factors of Global Digital Pathology Market are as follows: Lack of skilled personnel and reimbursement The digital pathology market is segmented on the lines of its product, end user and regional. Based on product segmentation it covers whole slide imaging, information management system storage and communication, image analysis informatics and others. Under end user segmentation it covers hospitals and diagnostic centers, educational institutes and pharmaceutical & biotechnology companies. The digital pathology market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides:

Slide 2

An overview of the global market for Digital Pathology and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. Identifications of new market opportunities and targeted promotional plans for Global Digital Pathology Market. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in the industry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets for Global Digital Pathology Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Visiopharm, Indica Labs, Digipath Inc., Koninklinje Philips N. V., Hamamatsu Photonics K. K., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem), Nikon Corporation, Pixcelldata Ltd., Glencoe Software Inc., and Definiens AG.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. Request A Sample Report: The Global Digital Pathology Market has been segmented as below: By Product Segment Analysis Whole Slide Imaging Information Management System Storage & Communication Image Analysis – Informatics Others By End-user Analysis Hospitals and diagnostic centers Educational Institutes Pharmaceutical & biotechnology companies By Regional Analysis North America Europe Asia-Pacific Rest of the World Table of Contents

Slide 3

INTRODUCTION Research Methodology Executive Summary Premium Insights Market Overview Digital Pathology Market, By Product 7 Digital Pathology Market, By Type Digital Pathology Market, By End User Digital Pathology Market, By Application Global Digital Pathology Market, By Region 11 Competitive Landscape Company Profiles Introduction Leica Biosystems Nussloch GMBH (Subsidiary of Danaher Corp) Ventana Medical Systems, Inc. (Member of Roche Group) Hamamatsu Photonics K.K. 3dhistech Ltd. Philips Healthcare Apollo Enterprise Imaging Corp. (Formerly Apollo Pacs, Inc.) Xifin, Inc. Definiens AG Visiopharm A/S Omnyx, LLC (Venture By Ge Healthcare and UPMC) Corista LLC

Slide 4

Media Contact Contact Person: John Bay Email: Phone: +1-855-984-1862 Country: United States Website:

Summary: The Global Digital Pathology Market is expected to exceed more than US$ 1052 million by 2022 and will grow at a CAGR of more than 12% in the given forecast period.

Tags: digital pathology market